About Us
Wayfinder’s team of seasoned experts in RNA biophysics, molecular biology and machine learning is dedicated to pioneering RNA-targeting small molecule therapies.
Our Scientific Advisory Board is composed of industry leaders in drug discovery and development with a successful history of bringing therapies to the clinic and to the market.
Our Mission: Discovering treatments for currently incurable diseases
Leadership
-
Jason Fontana, PhD
Founder & CEO
-
David Sparkman-Yager, PhD
Founder & CTO
-
Chuhern Hwang, PhD
Founder & Head of Drug Discovery
-
Michelle Kriner, PhD
Head of Program Development
-
Rao Talasila, MSc
Head of Machine Learning
Scientific Advisory Board
-
Michael Kauffman, MD PhD
CEO at Nereid Therapeutics
-
Wayne Gombotz, PhD
fmr CTO at Alpine Immune Sciences
-
Lance Stewart, PhD
Interim Executive Director
at Institute for Protein Design -
Nick Terrett, PhD
Medicinal Chemistry Advisor
fmr Merck, GSK, Pfizer -
Jay Rothstein, PhD
CSO at Lifordi Immunotherapeutics
-
Tom McCauley, PhD
CEO at Neptune Bio
Our Investors